Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.39 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.39 |
| ▸ | FDPS | P14324 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | LCK | P06239 | 1/20 | 0.38 |
| ▸ | PPARD | Q03181 | 1/20 | 0.38 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.38 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.38 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.37 |
| ▸ | BLM | P54132 | 1/20 | 0.37 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.36 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29218960 | 0.95 | GPR84 (0.42) | GPR84FFAR1FDPSMAPTLCK | |
| SCHEMBL31212517 | 0.95 | GPR84 (0.42) | GPR84FFAR1FDPSMAPTLCK | |
| SCHEMBL15412278 | 0.91 | GPR84 (0.44) | GPR84FFAR1FDPSMAPTLCK | |
| SCHEMBL9331686 | 0.91 | GPR84 (0.44) | GPR84FFAR1FDPSMAPTLCK | |
| SCHEMBL11355575 | 0.91 | GPR84 (0.42) | GPR84FFAR1FDPSMAPTLCK | |
| SCHEMBL2904335 | 0.90 | FDPS (0.46) | GPR84FFAR1FDPSMAPTLCK | |
| SCHEMBL2902795 | 0.90 | GPR84 (0.43) | GPR84FFAR1FDPSMAPTLCK | |
| SCHEMBL9574955 | 0.89 | GPR84 (0.46) | GPR84FFAR1FDPSMAPTLCK | |
| SCHEMBL31620705 | 0.89 | GPR84 (0.40) | GPR84FFAR1FDPSMAPTLCK | |
| SCHEMBL3388718 | 0.88 | GPR84 (0.38) | GPR84FFAR1MAPTLCKPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 175 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3632994-B1 | OIL-BASED INKJET INK | RISO KAGAKU CORP (JP) | 2024-01-24 | — | — | EP | claimed |
| EP-3397615-B1 | MIXED DECYL MERCAPTANS COMPOSITIONS AND METHODS OF MAKING SAME | CHEVRON PHILLIPS CHEMICAL CO LP (US) | 2021-08-18 | — | — | EP | claimed |
| EP-2583663-B1 | OIL-IN-WATER TYPE EMULSION SKIN COSMETIC | SHISEIDO CO LTD (JP) | 2019-04-03 | — | — | EP | claimed |
| EP-3397615-A1 | MIXED DECYL MERCAPTANS COMPOSITIONS AND METHODS OF MAKING SAME | Chevron Phillips Chemical Company LP (US) | 2018-11-07 | — | — | EP | claimed |
| EP-2114377-B1 | CONTROLLED RELEASE OF ACTIVES IN SKIN | UNIV RUTGERS (US) | 2018-10-17 | — | — | EP | claimed |
| US-10000590-B2 | Mixed decyl mercaptans compositions and use thereof as chain transfer agents | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2018-06-19 | — | — | US | claimed |
| US-20180105623-A1 | Mixed Decyl Mercaptans Compositions and Use Thereof as Chain Transfer Agents | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2018-04-19 | — | — | US | claimed |
| US-9879102-B2 | Mixed decyl mercaptans compositions and use thereof as chain transfer agents | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2018-01-30 | — | — | US | claimed |
| US-20170291872-A1 | Mixed Decyl Mercaptans Compositions and Methods of Making Same | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2017-10-12 | — | — | US | claimed |
| WO-2017116540-A9 | MIXED DECYL MERCAPTANS COMPOSITIONS AND METHODS OF MAKING SAME | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2017-08-17 | — | — | WO | claimed |
| EP-0651990-B1 | Composition based on C12-C20 esters for make-up removal | OREAL (FR) | 1998-10-14 | — | — | EP | claimed |
| CN-1182365-A | Pharmaceutical compostion for transdermic delivery | SANOFI SA (FR) | 1998-05-20 | — | — | CN | claimed |
| EP-0593192-B1 | Chromogenic composition for use in pressure-sensitive record material | WIGGINS TEAPE GROUP LTD (GB) | 1997-03-26 | — | — | EP | claimed |
| EP-0520639-B1 | Solvent compositions for use in pressure-sensitive copying paper | WIGGINS TEAPE GROUP LTD (GB) | 1996-12-18 | — | — | EP | claimed |
| US-5478380-A | Comprising methyl palmitate and/or fatty acid esters vehicle | THE WIGGINS TEAPE GROUP LIMITED (GB) | 1995-12-26 | — | — | US | claimed |
| US-5472489-A | Mixture of vegetable oil and fatty acid ester | THE WIGGINS TEAPE GROUP LIMITED (GB) | 1995-12-05 | — | — | US | claimed |
| EP-0593192-A2 | Chromogenic composition for use in pressure-sensitive record material | The Wiggins Teape Group Limited (GB) | 1994-04-20 | — | — | EP | claimed |
| US-5281266-A | Vegetable oil, mono- or di-functional ester of nonaromatic carboxylic acid | THE WIGGINS TEAPE GROUP LIMITED (GB) | 1994-01-25 | — | — | US | claimed |
| EP-0520639-A1 | Solvent compositions for use in pressure-sensitive copying paper | The Wiggins Teape Group Limited (GB) | 1992-12-30 | — | — | EP | claimed |
| EP-0334956-A1 | HEMOLYSIS INHIBITOR AND MEDICAL RESIN COMPOSITION, MEDICAL IMPLEMENT, AND BLOOD-PRESERVING FLUID CONTAINING THE SAME | Kao Corporation (JP) | 1989-10-04 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180105623-A1 | Mixed Decyl Mercaptans Compositions and Use Thereof as Chain Transfer Agents | MPST, MBOAT1, BHMT2 | GPR84 2600/4885FFAR1 303/4885FDPS 1296/4885 |
| US-10000590-B2 | Mixed decyl mercaptans compositions and use thereof as chain transfer agents | MPST, MBOAT1, BHMT2 | GPR84 2600/4885FFAR1 303/4885FDPS 1296/4885 |
| US-20170291872-A1 | Mixed Decyl Mercaptans Compositions and Methods of Making Same | MGMT, BHMT2, MPST | GPR84 3284/4885FFAR1 1314/4885FDPS 1695/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.